Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. AriBio H&B Co., Ltd.
WARNING LETTER
•AriBio H&B Co., Ltd.•October 19, 2021

AriBio H&B Co., Ltd. – FDA Warning Letter, Oct 19, 2021

Record Details

The FDA issued a Warning Letter to AriBio H&B Co., Ltd., a human drug manufacturer in South Korea, following the detention and refusal of admission of their "Hand Sanitizer Original" product into the U.S. The FDA's laboratory testing revealed the product, labeled to contain 70% w/v anhydrous ethanol, only contained an average of 58% w/v ethanol, falling below the declared strength and the CDC's recommended minimum of 60% for effective hand sanitizers. This renders the product adulterated under section 501(c) of the FD&C Act.

Furthermore, the subpotency and deficiencies in the firm's response to requested information during a November 20, 2020 teleconference indicate that the quality assurance system is not functioning in accordance with Current Good Manufacturing Practice (CGMP) requirements, leading to adulteration under section 501(a)(2)(B). The firm failed to provide documentation for methanol content testing or a scientific rationale for their ethanol content test method, violating 21 CFR 211.84 regarding raw material testing.

The product is also misbranded under sections 502(a) and (x) of the FD&C Act. The label falsely claims the product is a "Dietary Supplement" despite its intended use as a topical antiseptic, and it fails to disclose a domestic address or telephone number for reporting serious

Company
AriBio H&B Co., Ltd.
Inspection date
October 19, 2021
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Francis Godwin (Director)
  • Ho Dong Yang
  • Kevin Maguire
View Company Profile

ID · 106e6535-a7af-45c3-ac3a-46828bdd56d9

Violation Codes10
21 U.S.C. 351(c)21 U.S.C. 352(a)21 U.S.C. 352(x)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 CFR 211.8421 CFR 21021 CFR 21121 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AriBio H&B Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.